| Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study ME Weinblatt, EC Keystone, DE Furst, AF Kavanaugh, EK Chartash, ... Annals of the rheumatic diseases 65 (6), 753-759, 2006 | 268 | 2006 |
| Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines. DJ Schendel, B Gansbacher, R Oberneder, M Kriegmair, A Hofstetter, ... The Journal of Immunology 151 (8), 4209-4220, 1993 | 200 | 1993 |
| Most visits of most patients with rheumatoid arthritis to most rheumatologists do not include a formal quantitative joint count T Pincus, OG Segurado Annals of the Rheumatic Diseases 65 (6), 820-822, 2006 | 151 | 2006 |
| Uses and compositions for treatment of rheumatoid arthritis JR Medich, H Kupper, JD Kent, JL Perez, EH Sasso, O Segurado, ... US Patent App. 11/800,531, 2008 | 147 | 2008 |
| Rheumatoid arthritis joint progression in sustained remission is determined by disease activity levels preceding the period of radiographic assessment D Aletaha, J Funovits, FC Breedveld, J Sharp, O Segurado, JS Smolen Arthritis & Rheumatism 60 (5), 1242-1249, 2009 | 138 | 2009 |
| The Symptom Intensity Scale, fibromyalgia, and the meaning of fibromyalgia-like symptoms. F Wolfe, JJ Rasker The Journal of rheumatology 33 (11), 2291-2299, 2006 | 95* | 2006 |
| An index of patient reported outcomes (PRO-Index) discriminates effectively between active and control treatment in 4 clinical trials of adalimumab in rheumatoid arthritis. T Pincus, C Chung, OG Segurado, I Amara, GG Koch The Journal of Rheumatology 33 (11), 2146-2152, 2006 | 93 | 2006 |
| Relative efficiencies of physician/assessor global estimates and patient questionnaire measures are similar to or greater than joint counts to distinguish adalimumab from … T Pincus, I Amara, OG Segurado, M Bergman, GG Koch The Journal of Rheumatology 35 (2), 201-205, 2008 | 83 | 2008 |
| Uses and compositions for treatment of rheumatoid arthritis JR Medich, H Kupper, JL Perez, JD Kent, EH Sasso, O Segurado, ... US Patent App. 13/280,613, 2012 | 80 | 2012 |
| Clinical assessment of pain, tolerability, and preference of an autoinjection pen versus a prefilled syringe for patient self-administration of the fully human, monoclonal … A Kivitz, S Cohen, JE Dowd, W Edwards, S Thakker, FR Wellborne, ... Clinical therapeutics 28 (10), 1619-1629, 2006 | 77 | 2006 |
| Expression and function of a variant T cell receptor complex lacking CD3-gamma. P Pérez-Aciego, B Alarcon, A Arnaiz-Villena, C Terhorst, M Timon, ... Journal of Experimental Medicine 174 (2), 319-326, 1991 | 75 | 1991 |
| Cost-effectiveness of sequential therapy with tumor necrosis factor antagonists in early rheumatoid arthritis A Davies, MA Cifaldi, OG Segurado, MH Weisman The Journal of Rheumatology 36 (1), 16-26, 2009 | 54 | 2009 |
| Comparison between HLA-DRB and DQ DNA sequences and classic serological markers as Type 11 (insulin-dependent) diabetes mellitus predictive risk markers in the Spanish population JL Vicario, J Martinez-Laso, A Corell, JM Martin-Villa, P Morales, G Lledo, ... Diabetologia 35 (5), 475-481, 1992 | 52 | 1992 |
| Candidate early predictors for progression to joint damage in systemic juvenile idiopathic arthritis. C Sandborg, TH Holmes, T Lee, K Biederman, DA Bloch, H Emery, ... The Journal of rheumatology 33 (11), 2322-2329, 2006 | 51 | 2006 |
| Clinical significance of serum and CSF findings in the Guillain-Barré syndrome and related disorders OG Segurado, H Krüger, HG Mertens Journal of neurology 233 (4), 202-208, 1986 | 42 | 1986 |
| Greater reduction of knee than hip pain in osteoarthritis treated with naproxen, as evaluated by WOMAC and SF-36 O Svensson, M Malmenäs, L Fajutrao, EM Roos, LS Lohmander Annals of the rheumatic diseases 65 (6), 781-784, 2006 | 38 | 2006 |
| Selective concentration of anti‐Purkinje cell antibody in the CSF of two patients with paraneoplastic cerebellar degeneration F Graus, OG Segurado, E Tolosa Acta neurologica scandinavica 78 (3), 210-213, 1988 | 28 | 1988 |
| Vectra DA for the objective measurement of disease activity in patients with rheumatoid arthritis OG Segurado, EH Sasso Clin Exp Rheumatol 32 (Suppl 85), S29-S34, 2014 | 27 | 2014 |
| HUMIRA® Pen: a novel autoinjection device for subcutaneous injection of the fully human monoclonal antibody adalimumab A Kivitz, OG Segurado Expert review of medical devices 4 (2), 109-116, 2007 | 26 | 2007 |
| Multibiomarker disease activity score and C-reactive protein in a cross-sectional observational study of patients with rheumatoid arthritis with and without concomitant … YC Lee, J Hackett, M Frits, CK Iannaccone, NA Shadick, ME Weinblatt, ... Rheumatology 55 (4), 640-648, 2015 | 21 | 2015 |
theodore pincusclinical professor of medicineVerified email at nyumc.org
